Synthesis of Ellagic Acid Glucoside Using Glucansucrase from Leuconostoc and Characterization of This Glucoside As a Functional Neuroprotective Agent

Overview

Journal AMB Express

Date 2021 Jul 21

PMID 34287737

Citations 3

Authors

Hyejin Yu

Hana Jeong

Kwang-Yeol Yang

Jeong-Yong Cho

In Ki Hong

Seung-Hee Nam

Affiliations

Soon will be listed here.

Abstract

Ellagic acid glucoside was synthesized via transglucosylation using sucrose and glucansucrase derived from Leuconostoc mesenteroides B-512 FMCM. After such enzymatic synthesis, the product was purified by 50% ethyl acetate fraction and C18 column chromatography. Modification of ellagic acid glucoside was verified by LC-MS/MS at m/z 485.1 (M + Na) and m/z 531.1 (M + 3Na). The yield of ellagic acid glucoside was 69% (3.47 mM) by response surface methodology using 150 mM sucrose, 300 mU/mL glucansucrase, and 5 mM ellagic acid. The synthesized ellagic acid glucoside showed improved water solubility, up to 58% higher brain nerve cell (SH-SY5Y) protective effect, threefold higher cortisol reducing effect, and fourfold stronger inhibitory effect on acetylcholinesterase (AChE) than ellagic acid. These results indicate that ellagic acid glucoside could be used as a neuroprotective agent.

Citing Articles

Anticancer Activity and Mechanism of Action of Bark Decoction in Gastric Adenocarcinoma Cancer Cell Line.

Pisanti S, Penna S, Sposito S, Esposito T, Mencherini T, Celano R Int J Mol Sci. 2024; 25(17).

PMID: 39273132 PMC: 11395395. DOI: 10.3390/ijms25179183.

Chemo- and bio-informatics insight into anti-cholinesterase potentials of berries and leaves of Myrtus communis L., Myrtaceae: an in vitro/in silico study.

Hussein B, Karimi I, Yousofvand N BMC Complement Med Ther. 2023; 23(1):421.

PMID: 37990185 PMC: 10664585. DOI: 10.1186/s12906-023-04241-z.

LC-ESI-QTOF/MS characterization of antimicrobial compounds with their action mode extracted from vine tea () leaves.

Umair M, Sultana T, Xiaoyu Z, Senan A, Jabbar S, Khan L Food Sci Nutr. 2022; 10(2):422-435.

PMID: 35154679 PMC: 8825723. DOI: 10.1002/fsn3.2679.

References

Nam S, Kim Y, Walsh M, Wee Y, Yang K, Ko J . Synthesis and Functional Characterization of Caffeic Acid Glucoside Using Leuconostoc mesenteroides Dextransucrase. J Agric Food Chem. 2017; 65(13):2743-2750. DOI: 10.1021/acs.jafc.7b00344. View

Moon Y, Nam S, Kang J, Kim Y, Lee J, Kang H . Enzymatic synthesis and characterization of arbutin glucosides using glucansucrase from Leuconostoc mesenteroides B-1299CB. Appl Microbiol Biotechnol. 2007; 77(3):559-67. DOI: 10.1007/s00253-007-1202-7. View

Onodera K, Tsuha K, Yasumoto-Hirose M, Tsuha K, Hanashiro K, Naoki H . Okicamelliaside, an extraordinarily potent anti-degranulation glucoside isolated from leaves of Camellia japonica. Biosci Biotechnol Biochem. 2010; 74(12):2532-4. DOI: 10.1271/bbb.100630. View

Fontaine B, Nelson K, Lyles J, Jariwala P, Garcia-Rodriguez J, Quave C . Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity. Front Microbiol. 2017; 8:496. PMC: 5362615. DOI: 10.3389/fmicb.2017.00496. View

Priyadarsini K, Khopde S, Kumar S, Mohan H . Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 2002; 50(7):2200-6. DOI: 10.1021/jf011275g. View

Baradaran Rahimi V, Askari V, Mousavi S . Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study. Biomed Pharmacother. 2018; 108:1712-1724. DOI: 10.1016/j.biopha.2018.10.024. View

Cho H, Kim S, Lee S, Park J, Kim S, Chun H . Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology. 2008; 29(4):656-62. DOI: 10.1016/j.neuro.2008.03.004. View

Bertrand A, Morel S, Lefoulon F, Rolland Y, Monsan P, Remaud-Simeon M . Leuconostoc mesenteroides glucansucrase synthesis of flavonoid glucosides by acceptor reactions in aqueous-organic solvents. Carbohydr Res. 2006; 341(7):855-63. DOI: 10.1016/j.carres.2006.02.008. View

Moon Y, Lee J, Ahn J, Nam S, Oh D, Park D . Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB. J Agric Food Chem. 2006; 54(4):1230-7. DOI: 10.1021/jf052359i. View

10.

Sun Z, Zhang L, Zhu S, Chen W, Mei B . Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage. Neurosci Bull. 2010; 26(1):8-16. PMC: 5560379. DOI: 10.1007/s12264-010-0813-7. View

11.

Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S . Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. J Nutr Sci Vitaminol (Tokyo). 2006; 52(5):383-8. DOI: 10.3177/jnsv.52.383. View

12.

Nam S, Park J, Jun W, Kim D, Ko J, Abd El-Aty A . Transglycosylation of gallic acid by using Leuconostoc glucansucrase and its characterization as a functional cosmetic agent. AMB Express. 2017; 7(1):224. PMC: 5741567. DOI: 10.1186/s13568-017-0523-x. View

13.

Robyt J, Yoon S, Mukerjea R . Dextransucrase and the mechanism for dextran biosynthesis. Carbohydr Res. 2008; 343(18):3039-48. DOI: 10.1016/j.carres.2008.09.012. View

14.

Liu Y, Yu S, Wang F, Yu H, Li X, Dong W . Chronic administration of ellagic acid improved the cognition in middle-aged overweight men. Appl Physiol Nutr Metab. 2017; 43(3):266-273. DOI: 10.1139/apnm-2017-0583. View

15.

Farbood Y, Sarkaki A, Dianat M, Khodadadi A, Haddad M, Mashhadizadeh S . Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury. Life Sci. 2015; 124:120-7. DOI: 10.1016/j.lfs.2015.01.013. View

16.

Yoshimura M, Watanabe Y, Kasai K, Yamakoshi J, Koga T . Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem. 2005; 69(12):2368-73. DOI: 10.1271/bbb.69.2368. View